首页> 外文期刊>Current Gene Therapy >Heparan Sulphate Proteoglycans and Viral Vectors : Ally or Foe?
【24h】

Heparan Sulphate Proteoglycans and Viral Vectors : Ally or Foe?

机译:硫酸乙酰肝素蛋白聚糖和病毒载体:盟友还是敌人?

获取原文
获取原文并翻译 | 示例
       

摘要

The attachment of viruses to the host cell surface is a critical stage that will largely condition cell permissivity and productive infection. The understanding of such mechanisms is therefore essential for gene therapy applications involving viruses, as this step will influence both targeting and delivery efficiency of the gene of interest. Viral attachment depends upon the recognition and binding of viral envelope/capsid proteins to specific cellular receptors that can be from very diverse origins. Amongst them are heparan sulphate proteoglycans (HSPGs), a family of glycoproteins which, through the large binding properties of their heparan sulphate (HS) polysaccharide chains, serve as attachment receptor for a great number of viruses. The aim of this review is to provide an update on the multiple roles of HSPGs during viral infection, with a special focus on viruses used as gene delivery vectors. Consequences of HS binding for gene therapy applications will be assessed, as well as the various strategies that have been developed to potentiate the advantages or to overcome the drawbacks resulting from viral vector interaction with HS.
机译:病毒在宿主细胞表面的附着是一个关键阶段,它将在很大程度上限制细胞的介导性和生产性感染。因此,对这种机制的理解对于涉及病毒的基因治疗应用至关重要,因为此步骤将影响目标基因的靶向和递送效率。病毒附着取决于病毒包膜/衣壳蛋白与特定细胞受体的识别和结合,这些细胞受体可以来自非常不同的来源。其中包括硫酸乙酰肝素蛋白聚糖(HSPG),这是一种糖蛋白家族,通过其硫酸乙酰肝素(HS)多糖链的强大结合特性,可作为多种病毒的附着受体。这篇综述的目的是提供关于HSPG在病毒感染过程中的多种作用的更新,特别关注用作基因传递载体的病毒。将评估HS结合在基因治疗应用中的后果,以及已开发出的各种策略,以增强病毒载体与HS相互作用所产生的优势或克服其弊端。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号